Filter
7632
Filtered Results: 7632
Text search:
number
of
patients
Featured
Recommendations
731
New Publications
1929
Language
Document type
No document type
4300
Studies & Reports
1174
Guidelines
1075
Manuals
385
Strategic & Response Plan
228
Fact sheets
168
Training Material
127
Situation Updates
98
Resource Platforms
24
Infographics
19
Online Courses
17
Brochures
15
Dashboards/Maps
1
Videos
1
Countries / Regions
India
433
Global
253
Kenya
212
South Africa
212
Sierra Leone
194
Liberia
178
Western and Central Europe
162
Ethiopia
152
Uganda
139
Nigeria
134
Africa
115
Malawi
114
Nepal
112
Latin America and the Carribbean
108
Tanzania
107
Zambia
97
Rwanda
96
Bangladesh
92
Myanmar / Burma
86
Ghana
85
Syria
82
Ukraine
79
Namibia
63
Philippines
57
Congo, Democratic Republic of
56
Eastern Europe
56
Russia
55
Guinea
54
Zimbabwe
48
West and Central Africa
48
South–East Asia Region
48
Lesotho
47
Cambodia
46
Mozambique
46
East and Southern Africa
45
Middle East and North Africa
44
Asia
43
South Sudan
41
Haiti
40
Germany
38
Indonesia
35
Senegal
34
Brazil
32
Botswana
31
Burkina Faso
30
Eastern Europe and Central Asia
29
Cameroon
27
Yemen
24
Benin
22
Eswatini/ Swaziland
21
Colombia
19
Venezuela
19
Pakistan
16
Western Pacific Region
16
USA
15
Madagascar
15
Mali
13
Central African Republic
13
Iraq
12
Afghanistan
12
Albania
12
Tajikistan
12
Thailand
11
Sudan
11
Peru
11
Georgia
11
Somalia
10
Lebanon
10
Sri Lanka
10
Jordan
9
Chile
9
Palestine
9
Southern Africa
9
Laos
9
Moldova
9
Vietnam
9
Côte d’Ivoire / Ivory Coast
8
Angola
8
Paraguay
8
North America
8
United Kingdom
8
China
7
North Macedonia
6
Bolivia
6
Armenia
6
Turkey
5
Chad
5
Argentina
5
Ecuador
5
Mexico
5
Kazakhstan
5
Jamaica
5
France
5
Guinea-Bissau
4
Togo
4
Gambia
4
Hungary
4
Bhutan
4
Poland
4
Kyrgyzstan
4
Spain
4
Saudi Arabia
3
Niger
3
Singapore
3
Papua New Guinea
3
Serbia
3
El Salvador
3
Greece
3
Libya
3
Canada
3
Timor Leste/ East Timor
3
Romania
3
Uzbekistan
3
Mauritius
3
Morocco
2
Egypt
2
Ireland
2
Switzerland
2
Burundi
2
Honduras
2
Guatemala
2
Other region
2
Bulgaria
2
Lithuania
2
Slovakia
2
Iran
2
Australia
2
Portugal
2
Malaysia
1
Mauritania
1
Austria
1
Nicaragua
1
Fiji
1
Solomon Islands
1
North Korea
1
Mongolia
1
Congo-Brazzaville
1
Qatar
1
Estonia
1
Gabon
1
Turkmenistan
1
Japan
1
Denmark
1
Belgium
1
Maldives
1
Tunisia
1
Norway
1
Belarus
1
French Guyana
1
Israel
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
2849
Clinical Guidelines
692
Public Health
421
Women & Child Health
297
Key Resources
234
Capacity Building
163
Pharmacy & Technologies
102
Annual Report MEDBOX
2
Toolboxes
COVID-19
848
Mental Health
613
HIV
603
TB
496
Ebola
315
Caregiver
257
Rapid Response
255
AMR
248
NTDs
220
Conflict
180
NCDs
175
Pharmacy
166
Disability
146
Refugee
123
Planetary Health
122
Global Health Education
76
Cholera
64
Natural Hazards
58
Zika
49
Specific Hazards
44
Health Financing Toolbox
41
Polio
38
Social Ethics
26
Typhoon
3
South Sudan
1
Health Financing
1
A living WHO guideline on drugs for covid-19
recommended
BMJ 2020; 370 doi: https://doi.org/10.1136/bmj.m3379
Rapid Recommendation and visual graph. This is the fifth version (update 4) of the living guideline (BMJ 2020;370:m3379). When citing this article, please consider adding the update ... and date of access for clarity. The publication of the RECOVERY and REMAP-CAP randomised controlled trials triggered this guideline update, resulting in a strong recommendation for interleukin-6 (IL-6) receptor blockers (tocilizumab or sarilumab) in patients with severe or critical covid-19.
Prior recommendations: (a) A recommendation not to use ivermectin in patients with covid-19, regardless of disease severity, except in the context of a clinical trial; (b) a strong recommendation against the use of hydroxychloroquine in patients with covid-19, regardless of disease severity; (c) a strong recommendation against the use of lopinavir-ritonavir in patients with covid-19, regardless of disease severity; (d) a strong recommendation for systemic corticosteroids in patients with severe and critical covid-19; (e) a conditional recommendation against systemic corticosteroids in patients with non-severe covid-19; and (f) a conditional recommendation against remdesivir in hospitalised patients with covid-19.
The Covid-19 pandemic has so far infected more than 30 million people in the world, having major impact on global health with collateral damage. In Mozambique, a public state of emergency was declared at the end ... March 2020. This has limited people's movements and reduced public services, leading to a decrease in the number of people accessing health care facilities. An implementation research project, The Alert Community for a Prepared Hospital, has been promoting access to maternal and child health care, in Natikiri, Nampula, for the last four years. Nampula has the second highest incidence of Covid-19. The purpose of this study is to assess the impact of Covid-19 pandemic Government restrictions on access to maternal and child healthcare services. We compared health centres in Nampula city with healthcare centres in our research catchment area. We wanted to see if our previous research interventions have led to a more resilient response from the community.
METHODS: Mixed-methods research, descriptive, cross-sectional, retrospective, using a review of patient visit documentation. We compared maternal and child health care unit statistical indicators from March-May 2019 to the same time-period in 2020. We tested for significant changes in access to maternal and child health services, using KrushKall Wallis, One-way Anova and mean and standard deviation tests. We compared interviews with health professionals, traditional birth attendants and patients in the two areas. We gathered data from a comparable city health centre and the main city referral hospital. The Marrere health centre and Marrere General Hospital were the two Alert Community for a Prepared Hospital intervention sites.
RESULTS: Comparing 2019 quantitative maternal health services access indicators with those from 2020, showed decreases in most important indicators: family planning visits and elective C-sections dropped 28%; first antenatal visit occurring in the first trimester dropped 26%; hospital deliveries dropped a statistically significant 4% (p = 0.046), while home deliveries rose 74%; children vaccinated down 20%.
CONCLUSION: Our results demonstrated the negative collateral effects of Covid-19 pandemic Government restrictions, on access to maternal and child healthcare services, and highlighted the need to improve the health information system in Mozambique.
Chagas disease is a neglected tropical disease caused by the protozoan parasite Trypanosoma cruzi. It is a significant public health problem, affecting millions of people worldwide. And although it was described 110 years ago, only two old nitrohete...
Human African trypanosomiasis is caused by Trypanosoma brucei gambiense in West and Central Africa and by T. brucei rhodesiense in East Africa; both species are endemic in Uganda. Trypanosoma brucei gambiense accounts for 98% of all cases ... African trypanosomiasis, and T. brucei rhodesiense accounts for 2%. African trypanosomiasis has been targeted for eradication by the World Health Organization (WHO) and, as a result of control efforts, there has been a dramatic decrease (> 95%) in the number of reported cases worldwide.
Professional version as well as patient education
Background: Cardiovascular disease (CVD), mainly heart attack and stroke, is the
leading cause of premature mortality in low and middle income countries (LMICs).
Identifying and managing individuals at high risk ... CVD is an important strategy to prevent and control CVD, in addition to multisectoral population-based interventions to reduce CVD risk factors in the entire population.
Methods: We describe key public health considerations in identifying and managing individuals at high risk of CVD in LMICs.
Results: A main objective of any strategy to identify individuals at high CVD risk is to maximize the number of CVD events averted while minimizing the numbers of
individuals needing treatment. Scores estimating the total risk of CVD (e.g. ten-year risk of fatal and non-fatal CVD) are available for LMICs, and are based on the main CVD risk factors (history of CVD, age, sex, tobacco use, blood pressure, blood cholesterol and diabetes status). Opportunistic screening of CVD risk factors enables identification of persons with high CVD risk, but this strategy can be widely applied in low resource settings only if cost effective interventions are used (e.g. the WHO Package of Essential NCD interventions for primary health care in low resource settings package) and if treatment (generally for years) can be sustained, including continued availability ofaffordable medications and funding mechanisms that allow people to purchase medications without impoverishing them (e.g. universal access to health care). Thisalso emphasises the need to re-orient health systems in LMICs towards chronic diseases management.
Conclusion: The large burden of CVD in LMICs and the fact that persons with high
CVD can be identified and managed along cost-effective interventions mean that
health systems need to be structured in a way that encourages patient registration, opportunistic screening of CVD risk factors, efficient procedures for the management of chronic conditions (e.g. task sharing) and provision of affordable treatment for those with high CVD risk. The focus needs to be in primary care because that is where most of the population can access health care and because CVD programmes can be run effectively at this level.
Human African trypanosomiasis (HAT), also called sleeping sickness, is a parasitic infection that almost invariably progresses to death, unless treatment is provided. HAT caused devastating epidemics during the 20th century. Thanks to sustained and coordinated efforts during the past 15 years the ... of reported cases has fallen to a historic low. Fewer than 3,000 cases were reported in 2015, and the disease is targeted for elimination by the World Health Organization. Despite recent success, HAT still poses a heavy burden on the rural communities where this highly focal disease occurs, most notably in Central Africa. Since patients are also reported from non-endemic countries outside Africa, HAT should be considered in differential diagnosis for all travellers, tourists, migrants and expatriates who have visited or lived in endemic areas. In the absence of a vaccine, disease control relies on case detection and treatment, and vector control. Available drugs are sub-optimal, but ongoing clinical trials give hope for safer and simpler treatments.
Introduction Pharmacovigilance (PV) systems to monitor drug and vaccine safety are often inadequate in sub-Saharan
Africa. In Malawi, a PV enhancement initiative was introduced to address major barriers to PV.
Objective The objective of this initi...
Monkeypox Resources for Health Professionals
recommended
As global concern grows for the spread of the monkeypox virus, Wolters Kluwer is providing a number of free resources and clinical information to c...
Desta et al. Int J Ment Health Syst (2018) 12:38 https://doi.org/10.1186/s13033-018-0217-z
Interim emergency guidelines
The purpose of this pocketbook is to provide clear guidance on current best management practices for VHF across health-care facilities
Best Practice for the Care of Patients with Tuberculosis: a Guide for Low-Income Countries
recommended
2nd edition.
The practical aspects of TB patient care from the onset of symptoms to the completion of<...
Journal of Cancer Education
https://doi.org/10.1007/s13187-020-01935-7
Version 3.0
Accessed: 24.11.2019
This interim guidance to national health authorities and blood transfusion services outlines the steps required to collect convalescent whole blood (CWB) or plasma (CP) from Ebola virus disease (EVD) recovered patients for transfusion to ... with early EVD, as an empirical treatment modality.
Document contents:
Guidance on donor selection, screening, donation and handling of blood and plasma units;
guidance on transfusion of convalescent whole blood or plasma;
other considerations.
An evaluation of the prescribing patterns for under-five patients at a Tertiary Paediatric Hospital in Sierra Leone. J Basic Clin Pharma 2015;6:109-14.
The purpose of the Clinical Practice Guideline for Treatment of Patients with Anxiety Disorders in Primary Care is to provide professionals with pr...
The pandemic has emphasized the high risk of avoidable harm to patients, health workers, and the general public, and has identified a range of safe...
